Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
about
The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosusPredictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosusThe lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice.Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors.Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohortCardiovascular involvement in autoimmune diseases.Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicatorsLoxoprofen Sodium, a Non-Selective NSAID, Reduces Atherosclerosis in Mice by Reducing Inflammation.Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudyVitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudyMetabolic alterations and increased liver mTOR expression precede the development of autoimmune disease in a murine model of lupus erythematosus.Increased Pulse Wave Velocity in Systemic Lupus Erythematosus: A Meta-Analysis.Coronary calcification in SLE: comparison with the Multi-Ethnic Study of AtherosclerosisSemiquantified noncalcified coronary plaque in systemic lupus erythematosus.Association between depression and coronary artery calcification in women with systemic lupus erythematosusResveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.Proximal aortic stiffness is increased in systemic lupus erythematosus activity in children and adolescents.Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohortHigh-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.Recent progress in the treatment of lupus nephritis.Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis.A Randomized, Double-blind, Placebo-controlled Clinical Trial Examining the Effects of Green Tea Extract on Systemic Lupus Erythematosus Disease Activity and Quality of Life.Down-regulation of nectin-4 inhibits apoptosis in systemic lupus erythematous (SLE) through targeting Bcl-2/Bax pathway.Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease.High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis.Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification.Resveratrol Role in Autoimmune Disease-A Mini-Review.Relationship between Neutrophil-to-Lymphocyte Ratio and Pulse Wave Velocity in Young Patients with Systemic Lupus Erythematosus.Sleep quality in women with systemic lupus erythematosus: contributing factors and effects on health-related quality of life.The quality of life of patients with lupus erythematosus influences cardiovascular capacity in 6-minute walk test.Atherosclerosis in primary antiphospholipid syndrome.
P2860
Q28486062-15D74B1A-11C6-4DC1-B973-89B4B3A943EEQ33387473-BC167AD3-8710-44F3-909C-7CC255DDA616Q33389669-50232600-5CDA-4CC2-8729-A291AF9B2BD9Q33575750-51C1AF75-544C-4D45-8E52-46717CE02534Q33633643-FB6E03B1-D280-4775-8A77-087D5C5C6339Q33727314-61E83004-EE1C-4105-A768-BDEA8DC1D99DQ34081242-A3E3A173-F4EF-4839-81DF-382D70734A4AQ34101743-8A49DF8D-7DED-4D6E-8EC2-AFEBDC950AE7Q34109302-02866E3B-5179-4327-90B5-8B08FE5DE3BEQ34478798-9D108878-D395-4FC7-81BA-24280926C512Q34478814-0658A4D4-4CAE-4295-93C9-6F00CCDB93ACQ34506731-D307A9B3-E693-4A3A-8AAD-E2A5584F2E23Q36411062-9134B916-B219-4913-A4A8-66A1CA12E1D0Q36468887-D15E4211-73C1-4110-9BD3-39AA48EEE2E9Q36709328-AFA3BF87-71E0-4AF6-BA1B-2B8E7D29C9F8Q37160132-320F1625-C74B-4F36-A7C5-71675856D4A9Q37197627-3C602005-C12F-4FF9-9812-A6A5C869E1CEQ37221927-4C208CF5-1027-422B-9A90-97B7D45A85BDQ37330468-1615EAA9-1C0F-48FA-9ECA-0705A07C647BQ37369679-3DD83831-084C-46A0-9378-4A04FE89DD5CQ37406201-D57B9340-93BA-4B67-9778-3B4D9CC13CFFQ37670939-83755277-FBB1-4202-A25D-EE950A6788B8Q38010014-A2748EA4-4EA0-41B5-A08A-C4BD8B183CF8Q39028912-603C9DE4-8C47-4FDC-AC91-01E84215E267Q40171187-64D36AFB-7833-4E9A-A1BE-11A3826170C4Q40263037-457ACA01-FDD9-409F-B672-DC5A18FBBBC7Q43152580-5173D31C-76E6-4299-997B-74D095634026Q43197413-3AA61692-B517-4A5A-9709-4A0828C1B1A6Q46934492-36BB6027-2A00-4B91-A897-5FFDE42EB720Q47148225-A24B6DC1-0772-44D2-B5DD-B4AC434BFF0DQ47158536-AC643AAB-2D6C-43F4-BD87-8E686A7742C3Q47260542-B5A8A680-4650-4DE8-8296-9E577E59061FQ48073758-22089FF9-DA6C-4FAB-BB58-2793D698F5B2Q48260311-9CAAE7D7-76F4-4694-AF98-076B0A919AB5Q52852275-41C3183B-3195-4400-8A91-D13BCDAFA874
P2860
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
@ast
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
@en
type
label
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
@ast
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
@en
prefLabel
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
@ast
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
@en
P2093
P2860
P356
P1476
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
@en
P2093
Hein A Koomans
Peter E Westerweel
Remco K M A C Luyten
P2860
P304
P356
10.1002/ART.22568
P577
2007-05-01T00:00:00Z